Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Curdin Conrad Headshot

Curdin

Conrad

,

MD

Dermatology of Dermatology Functions, Head of the Policlinics and the Center for Psoriasis
University Hospital of Lausanne
Lausanne
,
Switzerland
Councilor Since: October 1, 2016
IPC Board Member
Dr. Curdin Conrad is a Professor of Dermatology at Lausanne University Hospital in Switzerland. He received his MD training at the University of Zurich and participated in the Postgraduate Course of Experimental Medicine and Biology. After completing dermatology training, he was a research fellow at MD Anderson Cancer Center in Houston, Texas, United States.

Dr. Conrad has a strong interest in inflammatory skin diseases, adaptive and innate immunity, and targeted immunotherapies, spanning basic science, translational research, and the clinic. He has fundamentally contributed to today’s understanding of psoriasis pathogenesis and has received several scientific awards for his basic and translational research. Over the years, Dr. Conrad has been actively involved in the teaching of evidence-based clinical and scientific dermatology and immunology.

He serves as an external scientific expert for several international societies and foundations. Dr. Conrad is a Board Member of the International Psoriasis Council (IPC), a member of the Board of Directors of the International Societies for Investigative Dermatology (ISID), and the current President of the European Society for Dermatological Research (ESDR).
Last Updated:
03/04/2026

Areas of Interest

Basic, Translational, & Clinical Research on Psoriasis, Psoriasis Subtypes, Biologic Treatments, and Side Effects

IPC Committees / Groups

Board Member, Research Committee

Languages Spoken

English, French, German

Involvement with Other Organization(s)

Dr. Conrad is a scientific advisor to the Swiss patient association and an advisor to Swiss national regulatory agencies (the Federal Office of Public Health and Swissmedic).

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026